T-cell lymphoma secondary to checkpoint inhibitor therapy.
Anand K, Ensor J, Pingali SR, Hwu P, Duvic M, Chiang S, Miranda R, Zu Y, Iyer S.
Anand K, et al. Among authors: pingali sr.
J Immunother Cancer. 2020 Feb;8(1):e000104. doi: 10.1136/jitc-2019-000104.
J Immunother Cancer. 2020.
PMID: 32114498
Free PMC article.
Review.